Clin2
NCT07597902Likely a fitNot yet recruiting

Testing antivirals to help Long COVID symptoms

Post-acute Sequelae of COVID-19Long COVID

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18–65 years old and have been diagnosed with Long COVID
  • You are not pregnant, breastfeeding, or planning pregnancy in the next 6 months
  • You have a clean urine drug screen (no methamphetamine, cocaine, PCP, or undisclosed amphetamines/opioids)
  • If you have depression, it must be mild to moderate and stable for at least 3 months with no suicidal thoughts
  • You do not have ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) or a prior ME/CFS diagnosis in the last 5 years

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06511063Recruiting· Phase 2
Antiviral trial for treating long covid symptoms

This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.

New York, New York
NCT06974084Not yet recruiting· Phase 2/Phase 3
Testing two drugs for long COVID symptoms

This trial tests if combining maraviroc and atorvastatin can help people with long COVID. You must have specific, persistent symptoms like brain fog, severe fatigue, or shortness of breath that started or got worse after a confirmed COVID-19 infection and have lasted over 6 months.

Tucson, Arizona
NCT07397910Not yet recruiting
A natural compound for long COVID inflammation

This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.

Murcia
NCT07285707Recruiting
Acupuncture and herbs for long COVID

This small study tests whether acupuncture and Chinese herbal medicine can help relieve common long COVID symptoms like fatigue, cough, brain fog, and pain. It might be a good fit if you are struggling with ongoing symptoms after COVID and are looking for a treatment approach that isn't just more medication.

Whittier, California
NCT06721949Recruiting· Phase 2/Phase 3
Taurine for long COVID symptoms

This trial tests if taking taurine, a natural amino acid supplement, can help reduce lingering symptoms of COVID-19 that last for months. If you have had COVID-19 and still have symptoms like fatigue or brain fog for at least 2 months after 3 months from your infection, this study might be for you.

Edmonton, Alberta
NCT07123727Recruiting· Phase 2
Testing Anktiva for long COVID symptoms

This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.

El Segundo, California

Hear when a new Post Acute Sequelae of COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.